PO3/01 After the trial is over: effective implementation of the RHIVA2 research programme promoting HIV testing and diagnosis in east London primary care
PO3/02 The Greek "Checkpoint" success story in safeguarding public health: First community-based prevention and testing centre in Greece diagnoses 30% of the 2017 national HIV cases.
PO3/03 IMPLEMENTATION OF HIV INFECTION HOSPITAL-BASED ACTIVE CASE FINDING IN SARDINA, ITALY: RESULST FROM THE SHOT PROJECT
PO3/04 A qualitative study of acceptability of rapid screening for HIV, Hepatitis B, and Hepatitis C among migrants in France (STRADA study)
PO3/05 Low access to HIV and HCV testing among People Who Inject Drugs (PWID) in Poland. Cross-sectional multicenter study 2017.
PO3/06 How can we test for HIV, HCV and syphilis - experience from Polish NGO.
PO3/07 Evaluation of a new strategy for screening migrants: the STRADA study design
PO3/08 S.A.M: the new homesampling service in Germany
PO3/09 The cost-effectiveness of an HCV outreach intervention for at-risk populations in London, UK
PO3/10 Two years on the road to Meet, Test and Treat Sex Workers in Rome: the need for targeted interventions.
PO3/11 2017 analysis from the community checkpoint in Cologne: Are we reaching the at risk patient populations for HIV and other sexually transmitted diseases (STIs)?
PO3/12 Prevention and promotion of welfare: the importance of conducting community screenings for HIV infection
Oral Presentations - Posters
PS3/01 The ENABLE study; High prevalence of undiagnosed blood borne virus infections (HBV, HCV, HIV) in urban emergency department attenders in England- a case for opportunistic testing?
PS3/02 SH:24 - An online sexual health service using digital technology to increase access to HIV testing in London
PS3/03 Tuberculosis in the time of HIV: what impede the injecting drug users (IDUs) from Romania to address diagnosis and treatment services for TB? Results from a mixed methods study
PS3/04 Hepatitis B and C testing strategies in healthcare and community settings in the EU/EEA: a systematic review
PS3/05 Evidence-based public health guidance for integrated HBV, HCV and HIV testing in Europe
Rigshospitalet, University of Copenhagen
CHIP, Department of Infectious Diseases
Section 2100, Finsencentret
DK-2100 Copenhagen Ø
Tel: +45 35 45 57 57
Fax: +45 35 45 57 58
Ann Isabelle von Lingen, Policy Officer
European AIDS Treatment Group (EATG)
Place Raymond Blyckaerts, 13
B-1050 Brussels, Belgium
Tel 32 2 626 96 41
Fax 32 2 644 33 07